Editas Medicine, Inc. financial data

Symbol
EDIT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
11 Hurley St., Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 397 % -36.7%
Debt-to-equity 78.7 % +92.6%
Return On Equity -113 % -164%
Return On Assets -63.5 % -108%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 83M shares +0.9%
Common Stock, Shares, Outstanding 82.7M shares +1.18%
Entity Public Float 384M USD -42.8%
Common Stock, Value, Issued 8K USD 0%
Weighted Average Number of Shares Outstanding, Basic 82.3M shares +8.39%
Weighted Average Number of Shares Outstanding, Diluted 82.3M shares +8.39%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 32.3M USD -58.6%
Research and Development Expense 199M USD +12.2%
General and Administrative Expense 72M USD +3.35%
Operating Income (Loss) -251M USD -48.5%
Nonoperating Income (Expense) 14.1M USD -11.9%
Net Income (Loss) Attributable to Parent -237M USD -54.7%
Earnings Per Share, Basic -2.88 USD/shares -42.6%
Earnings Per Share, Diluted -2.88 USD/shares -42.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 132M USD +6.38%
Marketable Securities, Current 138M USD -30.6%
Assets, Current 289M USD -15.1%
Property, Plant and Equipment, Net 14.5M USD +20.5%
Operating Lease, Right-of-Use Asset 32.6M USD -3.34%
Other Assets, Noncurrent 5.22M USD -39.2%
Assets 342M USD -31.6%
Accounts Payable, Current 5.49M USD -33.6%
Employee-related Liabilities, Current 11.5M USD +2.09%
Accrued Liabilities, Current 45.9M USD +32.7%
Contract with Customer, Liability, Current 6.22M USD -24.3%
Liabilities, Current 77.2M USD +22.2%
Contract with Customer, Liability, Noncurrent 54.2M USD -10.7%
Operating Lease, Liability, Noncurrent 20.4M USD -16.4%
Other Liabilities, Noncurrent 3.07M USD +70.7%
Liabilities 207M USD +38.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 268K USD +35.4%
Retained Earnings (Accumulated Deficit) -1.47B USD -19.3%
Stockholders' Equity Attributable to Parent 134M USD -61.5%
Liabilities and Equity 342M USD -31.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -49.9M USD -39.4%
Net Cash Provided by (Used in) Financing Activities 192K USD
Net Cash Provided by (Used in) Investing Activities -4.75M USD -120%
Common Stock, Shares Authorized 195M shares 0%
Common Stock, Shares, Issued 82.7M shares +1.18%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -54.4M USD -335%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 135M USD +6.19%
Deferred Tax Assets, Valuation Allowance 389M USD +18.4%
Deferred Tax Assets, Gross 397M USD +17.7%
Operating Lease, Liability 35M USD -4.12%
Depreciation 1.41M USD -8.74%
Payments to Acquire Property, Plant, and Equipment 1.87M USD +1.69%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -237M USD -58.6%
Lessee, Operating Lease, Liability, to be Paid 39.9M USD -8.06%
Property, Plant and Equipment, Gross 46.1M USD +20.5%
Operating Lease, Liability, Current 14.7M USD +20.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.73M USD +15.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 17.1M USD +15.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.92M USD -28.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.08M USD -0.81%
Deferred Tax Assets, Operating Loss Carryforwards 171M USD +11.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 15.7M USD +14.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6M USD -15.2%
Operating Lease, Payments 3.85M USD -1.28%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 8.49M USD -7.62%
Share-based Payment Arrangement, Expense 21.4M USD +8.18%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%